<DOC>
	<DOCNO>NCT01345942</DOCNO>
	<brief_summary>This open label , two period , crossover study evaluate safety effect food pharmacokinetics RO5428029 healthy volunteer . In crossover design , healthy subject randomize receive single oral dose RO5428029 without food , washout period least 7 day dose follow-up 7 10 day last dose . Anticipated time study 21 day .</brief_summary>
	<brief_title>A Study Effect Food Pharmacokinetics RO5428029 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy volunteer , 18 60 year age inclusive Body mass index ( BMI ) 18 29.9 kg/m2 , inclusive , minimum weight 45 kg Female subject must surgically sterile postmenopausal Male subject partner childbearing potential must use 2 method contraception ( one barrier method ) duration study least 70 day last dose Pregnant lactate woman , male partner woman pregnant lactate Women reproductive potential History ( within 3 month screen ) alcohol consumption exceed 2 standard unit per day average ; alcohol consumption prohibit least 48 hour screen Positive test drug abuse History symptom significant disease Positive HIV , hepatitis B hepatitis C infection Participation investigational drug device study within 3 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>